Is adenomyomatosis associated with depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Adenomyomatosis is not directly associated with any specific psychiatric disorder. The provided evidence [ 1 ] discusses the comorbidities associated with atopic dermatitis, including depression and anxiety, but does not mention adenomyomatosis.

Key Points

  • Adenomyomatosis is a benign condition primarily affecting the gallbladder, characterized by an overgrowth of the organ's muscular wall and the formation of small outpouchings called Rokitansky-Aschoff sinuses.
  • This condition is considered a physical disorder of the gallbladder and biliary system rather than having psychiatric manifestations or associations.
  • While patients with adenomyomatosis may experience physical symptoms such as abdominal pain, these symptoms are not linked to psychiatric conditions.
  • Any psychological distress experienced by patients with adenomyomatosis would typically be secondary to dealing with a chronic medical condition rather than representing a direct pathophysiological relationship between adenomyomatosis and psychiatric disorders.

Considerations

  • If a patient with adenomyomatosis is experiencing psychiatric symptoms, these should be evaluated and treated independently as they likely represent separate clinical entities.
  • The evidence [ 1 ] highlights the importance of considering comorbidities in patients with chronic conditions, but it does not provide a direct link between adenomyomatosis and psychiatric disorders.

From the Research

Adenomyomatosis and Psychiatric Disorders

  • Adenomyosis is associated with a higher risk of anxiety and depression, with a poorer quality of life, as compared to uterine leiomyoma 2
  • The incidence of anxiety symptoms in patients with adenomyosis is 28.9%, with 10% of patients showing moderate-to-severe symptoms 2
  • The incidence of depressive symptoms in patients with adenomyosis is 14.4% 2
  • Risk factors for anxiety in patients with adenomyosis include being employed and perianal pain, while perianal pain is a risk factor for depression 2

Psychiatric Disorders

  • Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the global population 3
  • Selective serotonin reuptake inhibitors (SSRIs) are a mainstay of treatment for various psychiatric disorders, including major depression, dysthymia, panic disorder, obsessive-compulsive disorder, eating disorders, and premenstrual dysphoric disorder 3, 4
  • SSRIs have a unique mechanism of action, pharmacokinetics, pharmacodynamics, and side effect profile 3, 4

Adenomyomatosis Diagnosis and Management

  • Adenomyosis is a clinical condition characterized by the presence of endometrial glands in the myometrium of the uterus 5, 6
  • The most common presenting signs and symptoms of adenomyosis are abnormal uterine bleeding, chronic pelvic pain, and infertility 5, 6
  • Diagnosis of adenomyosis begins with clinical suspicion and is confirmed with transvaginal ultrasonography and pelvic magnetic resonance imaging 5
  • Treatment of adenomyosis typically starts with hormonal menstrual suppression, and patients may ultimately have a hysterectomy if symptoms are not controlled with medical therapy 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Selective serotonin-reuptake inhibitors: an update.

Harvard review of psychiatry, 1999

Research

Adenomyosis: Diagnosis and Management.

American family physician, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.